Please enable JavaScript to continue using this application.

Compare $CELU vs $INMB | Chartloom

Compare

$CELU vs $INMB

Celularity Inc · INmune Bio Inc

CELU

Celularity Inc

INMB

INmune Bio Inc

Compare $CELU vs $INMB

Comparing Celularity Inc and INmune Bio Inc

CELUCelularity Inc

INMBINmune Bio Inc

CELUCelularity Inc

Market cap

$45M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.0%

YTD performance

28.9%

52W performance

-27.4%

FCF yield

-29.3%

INMBINmune Bio Inc

Market cap

$50M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

22.7%

52W performance

-6.0%

FCF yield

-31.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CELU

INMB

Detailed metrics comparison

CELU

Celularity Inc

INMB

INmune Bio Inc

Market Cap

CELU$45M

INMB$50M

Enterprise Value

CELU$87M

INMB$32M

Price

CELU$1.56

INMB$1.89

P/E Ratio

CELUN/A

INMBN/A

P/S Ratio

CELU1.70x

INMB1,071.30x

EV/Sales

CELU3.27x

INMB703.08x

EV/EBITDA

CELU0.00x

INMB0.00x

P/B Ratio

CELU5.88x

INMB2.63x

P/FCF Ratio

CELUN/A

INMBN/A

EV/FCF

CELU-6.55x

INMB-2.02x

PEG Ratio

CELUN/A

INMBN/A

Forward P/E (NTM)

CELUN/A

INMBN/A

Forward P/S (NTM)

CELUN/A

INMBN/A

Revenue (TTM)

CELU$27M

INMB$0

Revenue Growth (YoY)

CELU-51.0%

INMB-100.0%

Forward Rev Growth

CELU0.0%

INMB150.6%

Gross Margin (TTM)

CELU24.4%

INMB0.0%

Operating Margin (TTM)

CELU0.0%

INMB0.0%

EBITDA Margin (TTM)

CELU-203.4%

INMB0.0%

Net Margin (TTM)

CELU-346.0%

INMB0.0%

FCF Margin (TTM)

CELU-49.9%

INMBN/A

Net Income (TTM)

CELU$-92M

INMB$-18M

FCF (TTM)

CELU$-13M

INMB$-16M

EPS (TTM)

CELU-$3.23

INMB-$0.69

ROE (TTM)

CELU-27244.0%

INMB-8287.0%

ROA (TTM)

CELU-7794.0%

INMB-6223.0%

ROIC (TTM)

CELU-9204.0%

INMB-8287.0%

Cash

CELU$6M

INMB$18M

Debt

CELU$48M

INMB$0

Net Cash/Debt

CELU$-42M

INMB$18M

Current Ratio (TTM)

CELU0.15x

INMB4.04x

Quick Ratio (TTM)

CELU0.14x

INMB3.94x

Debt/Equity (TTM)

CELU4.79x

INMB0.00x

Debt/Assets (TTM)

CELU0.0%

INMB0.0%

Interest Coverage (TTM)

CELUN/A

INMBN/A

Net Debt/EBITDA (TTM)

CELU0.00x

INMB0.00x

Beta

CELU0.88

INMB0.91

52W Performance

CELU-27.4%

INMB-6.0%

YTD Performance

CELU28.9%

INMB22.7%

% from 52W High

CELU-38.8%

INMB-27.3%

% from 52W Low

CELU178.5%

INMB73.4%

Asset Turnover (TTM)

CELU0.23x

INMB0.00x

FCF Yield (TTM)

CELU-29.3%

INMB-31.3%

Earnings Yield (TTM)

CELU-203.4%

INMB-36.6%

Dividend Yield (TTM)

CELUN/A

INMBN/A

Rule of 40

CELU-101.0

INMB-100.0

EV/GP/RG

CELUN/A

INMBN/A

Ticker research

View CELU research View INMB research

Metric	CELU Celularity Inc	INMB INmune Bio Inc
Market & Valuation
Market Cap	$45M	$50M
Enterprise Value	$87M	$32M
Price	$1.56	$1.89
P/E Ratio	N/A	N/A
P/S Ratio	1.70x	1,071.30x
EV/Sales	3.27x	703.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.88x	2.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.55x	-2.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$27M	$0
Revenue Growth (YoY)	-51.0%	-100.0%
Forward Rev Growth	0.0%	150.6%
Profitability
Gross Margin (TTM)	24.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-203.4%	0.0%
Net Margin (TTM)	-346.0%	0.0%
FCF Margin (TTM)	-49.9%	N/A
Net Income (TTM)	$-92M	$-18M
FCF (TTM)	$-13M	$-16M
EPS (TTM)	-$3.23	-$0.69
ROE (TTM)	-27244.0%	-8287.0%
ROA (TTM)	-7794.0%	-6223.0%
ROIC (TTM)	-9204.0%	-8287.0%
Financial Health
Cash	$6M	$18M
Debt	$48M	$0
Net Cash/Debt	$-42M	$18M
Current Ratio (TTM)	0.15x	4.04x
Quick Ratio (TTM)	0.14x	3.94x
Debt/Equity (TTM)	4.79x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	0.91
52W Performance	-27.4%	-6.0%
YTD Performance	28.9%	22.7%
% from 52W High	-38.8%	-27.3%
% from 52W Low	178.5%	73.4%
Efficiency & Yields
Asset Turnover (TTM)	0.23x	0.00x
FCF Yield (TTM)	-29.3%	-31.3%
Earnings Yield (TTM)	-203.4%	-36.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-101.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View CELU research	View INMB research

Valuation

P/S Ratio

CELU

1.70x

INMB

1,071.30x

EV/FCF

CELU

-6.55x

INMB

-2.02x

Growth & revenue

Revenue Growth TTM

CELU

-51.0%

INMB

-100.0%

Forward Revenue Growth

INMB

150.6%

CELU

0.0%

Profitability & performance

Gross Margin

CELU

24.4%

INMB

0.0%

ROE

INMB

-8287.0%

CELU

-27244.0%

FCF Yield %

CELU

-29.3%

INMB

-31.3%

52-Week Performance

INMB

-6.0%

CELU

-27.4%

Detailed metrics comparison

CELU

Celularity Inc

INMB

INmune Bio Inc

Market Cap

CELU$45M

INMB$50M

Enterprise Value

CELU$87M

INMB$32M

Price

CELU$1.56

INMB$1.89

P/E Ratio

CELUN/A

INMBN/A

P/S Ratio

CELU1.70x

INMB1,071.30x

EV/Sales

CELU3.27x

INMB703.08x

EV/EBITDA

CELU0.00x

INMB0.00x

P/B Ratio

CELU5.88x

INMB2.63x

P/FCF Ratio

CELUN/A

INMBN/A

EV/FCF

CELU-6.55x

INMB-2.02x

PEG Ratio

CELUN/A

INMBN/A

Forward P/E (NTM)

CELUN/A

INMBN/A

Forward P/S (NTM)

CELUN/A

INMBN/A

Revenue (TTM)

CELU$27M

INMB$0

Revenue Growth (YoY)

CELU-51.0%

INMB-100.0%

Forward Rev Growth

CELU0.0%

INMB150.6%

Gross Margin (TTM)

CELU24.4%

INMB0.0%

Operating Margin (TTM)

CELU0.0%

INMB0.0%

EBITDA Margin (TTM)

CELU-203.4%

INMB0.0%

Net Margin (TTM)

CELU-346.0%

INMB0.0%

FCF Margin (TTM)

CELU-49.9%

INMBN/A

Net Income (TTM)

CELU$-92M

INMB$-18M

FCF (TTM)

CELU$-13M

INMB$-16M

EPS (TTM)

CELU-$3.23

INMB-$0.69

ROE (TTM)

CELU-27244.0%

INMB-8287.0%

ROA (TTM)

CELU-7794.0%

INMB-6223.0%

ROIC (TTM)

CELU-9204.0%

INMB-8287.0%

Cash

CELU$6M

INMB$18M

Debt

CELU$48M

INMB$0

Net Cash/Debt

CELU$-42M

INMB$18M

Current Ratio (TTM)

CELU0.15x

INMB4.04x

Quick Ratio (TTM)

CELU0.14x

INMB3.94x

Debt/Equity (TTM)

CELU4.79x

INMB0.00x

Debt/Assets (TTM)

CELU0.0%

INMB0.0%

Interest Coverage (TTM)

CELUN/A

INMBN/A

Net Debt/EBITDA (TTM)

CELU0.00x

INMB0.00x

Beta

CELU0.88

INMB0.91

52W Performance

CELU-27.4%

INMB-6.0%

YTD Performance

CELU28.9%

INMB22.7%

% from 52W High

CELU-38.8%

INMB-27.3%

% from 52W Low

CELU178.5%

INMB73.4%

Asset Turnover (TTM)

CELU0.23x

INMB0.00x

FCF Yield (TTM)

CELU-29.3%

INMB-31.3%

Earnings Yield (TTM)

CELU-203.4%

INMB-36.6%

Dividend Yield (TTM)

CELUN/A

INMBN/A

Rule of 40

CELU-101.0

INMB-100.0

EV/GP/RG

CELUN/A

INMBN/A

Ticker research

View CELU research View INMB research

Metric	CELU Celularity Inc	INMB INmune Bio Inc
Market & Valuation
Market Cap	$45M	$50M
Enterprise Value	$87M	$32M
Price	$1.56	$1.89
P/E Ratio	N/A	N/A
P/S Ratio	1.70x	1,071.30x
EV/Sales	3.27x	703.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.88x	2.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-6.55x	-2.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$27M	$0
Revenue Growth (YoY)	-51.0%	-100.0%
Forward Rev Growth	0.0%	150.6%
Profitability
Gross Margin (TTM)	24.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-203.4%	0.0%
Net Margin (TTM)	-346.0%	0.0%
FCF Margin (TTM)	-49.9%	N/A
Net Income (TTM)	$-92M	$-18M
FCF (TTM)	$-13M	$-16M
EPS (TTM)	-$3.23	-$0.69
ROE (TTM)	-27244.0%	-8287.0%
ROA (TTM)	-7794.0%	-6223.0%
ROIC (TTM)	-9204.0%	-8287.0%
Financial Health
Cash	$6M	$18M
Debt	$48M	$0
Net Cash/Debt	$-42M	$18M
Current Ratio (TTM)	0.15x	4.04x
Quick Ratio (TTM)	0.14x	3.94x
Debt/Equity (TTM)	4.79x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.88	0.91
52W Performance	-27.4%	-6.0%
YTD Performance	28.9%	22.7%
% from 52W High	-38.8%	-27.3%
% from 52W Low	178.5%	73.4%
Efficiency & Yields
Asset Turnover (TTM)	0.23x	0.00x
FCF Yield (TTM)	-29.3%	-31.3%
Earnings Yield (TTM)	-203.4%	-36.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-101.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View CELU research	View INMB research